Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193805-26-000140·Mersana Therapeutics, Inc.
Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 59045L106
Event date: 2025-12-31
- Filing-level shares
- 0.00
- Percent of class
- 0%
- Schonfeld Strategic Advisors LLC
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-26-000140
- Form type
- SCHEDULE 13G/A
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership